1. Current updates on microRNAs as regulators of chemoresistance
   Metin Çalışkan et al, 2017, Biomedicine & Pharmacotherapy CrossRef
2. PPARβ/δ Agonist GW501516 Inhibits Tumorigenesis and Promotes Apoptosis of the Undifferentiated Nasopharyngeal Carcinoma C666-1 Cells by Regulating miR-206
   Linglan Gu et al, 2019, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
3. Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation
   Jing Liu et al, 2018, Cancer Biology & Therapy CrossRef
4. miR-125b suppresses oral oncogenicity by targeting the anti-oxidative gene PRXL2A
   Yi-Fen Chen et al, 2019, Redox Biology CrossRef
5. miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma
   Li-Li Mei et al, 2017, PLOS ONE CrossRef
6. MicroRNA-125 in immunity and cancer
   Jessica K. Wang et al, 2019, Cancer Letters CrossRef
7. MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
   Faezeh Tolue Ghasaban et al, 2023, Cancer Cell International CrossRef
8. The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
   Jin Liu et al, 2020, Bioscience Reports CrossRef
9. miR-125b-5p, miR-155-3p, and miR-214-5p and Target E2F2 Gene in Oral Squamous Cell Carcinoma
   Karolina Gołąbek et al, 2023, International Journal of Molecular Sciences CrossRef
10. Circulating miR-125b but not miR-125a correlates with acute exacerbations of chronic obstructive pulmonary disease and the expressions of inflammatory cytokines
    Hong-Ling Hu et al, 2017, Medicine CrossRef
11. The promising role of miRNAs in radioresistance and chemoresistance of nasopharyngeal carcinoma
    Haoyuan Xu et al, 2024, Frontiers in Oncology CrossRef
12. miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses
    Hesham A. El-Mahdy et al, 2023, Pathology - Research and Practice CrossRef
13. The therapeutic effect of miR-125b is enhanced by the prostaglandin endoperoxide synthase 2/cyclooxygenase 2 blockade and hampers ETS1 in the context of the microenvironment of bone metastasis
    Paola Maroni et al, 2018, Cell Death & Disease CrossRef
14. Non-coding RNAs in drug resistance of head and neck cancers: A review
    Fengsheng Dai et al, 2020, Biomedicine & Pharmacotherapy CrossRef
15. Cancer Hallmarks and MicroRNAs: The Therapeutic Connection
    Katrien Van Roosbroeck et al, 2017, miRNA and Cancer CrossRef
16. The Role of Non-Coding RNAs as Prognostic Factor, Predictor of Drug Response or Resistance and Pharmacological Targets, in the Cutaneous Squamous Cell Carcinoma
    Marianna Garofoli et al, 2020, Cancers CrossRef
17. Gaseous signaling molecules and their application in resistant cancer treatment: from invisible to visible
    Qingbin Cui et al, 2019, Future Medicinal Chemistry CrossRef